Scholars Central

ArticlePublished 26 Oct 2026

Leveraging Artificial Intelligence to Structure Next-Generation Sequencing Data for Precision Oncology Research: A Real-World Pancreatic Ductal Adenocarcinoma Liquid Biopsy Experience

Authors: Jacob Gabayan, Yousuf Altameemi, Ali Muhammad MD MBA

Journal of Cancer Clinical Trials

Volume 15 · Issue 5 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Precision oncology generates increasingly complex molecular datasets that can be difficult to organize and analyze efficiently. We evaluated 212 real-world pancreatic ductal adenocarcinoma liquid biopsy datasets and explored AI-assisted workflows to transform unstructured next-generation sequencing outputs into structured research datasets. The analysis characterized 99 unique biomarkers and genes and demonstrates the potential operational value of AI-enabled data structuring for research, biomarker assessment and future clinical trial matching.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Journal of Cancer Clinical Trials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cancer Clinical Trials
  • SubjectOncology & Cancer
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Jacob Gabayan”
  • BylineArticles whose byline prints “Yousuf Altameemi”
  • BylineArticles whose byline prints “Ali Muhammad MD MBA”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels